Loading…
A rash that’s more than skin deep
Discussion Neonatal lupus erythematosus is an acquired disease of the newborn caused by transplacental transfer of maternal anti-Ro/SSA, anti-La/SSB, and anti-U1 RNP antibodies, and has a frequency of 1 in 12500 to 20000 live births. 2 4 The condition might involve (in order of decreasing frequency)...
Saved in:
Published in: | BMJ (Online) 2018-01, Vol.360, p.k8-k8 |
---|---|
Main Authors: | , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-b248t-e97f54d0429339fb0a385e177b397a617cc86dfe96fb7109452f207fa63ead863 |
---|---|
cites | |
container_end_page | k8 |
container_issue | |
container_start_page | k8 |
container_title | BMJ (Online) |
container_volume | 360 |
creator | Chin, Xinyi Chan, Daisy Kwai Lin Chong, Jin Ho |
description | Discussion Neonatal lupus erythematosus is an acquired disease of the newborn caused by transplacental transfer of maternal anti-Ro/SSA, anti-La/SSB, and anti-U1 RNP antibodies, and has a frequency of 1 in 12500 to 20000 live births. 2 4 The condition might involve (in order of decreasing frequency) the dermatological, cardiac, hepatobiliary, and haematological systems. 2 4 5 6 Cutaneous manifestation is the commonest feature of neonatal lupus erythematosus and can present at birth 5 or within the first 4-6 weeks of life. 7 8 In one study, skin lesions were characterised as erythematous patches (91.7%), lesions resembling subacute cutaneous lupus erythematosus (50%), petechiae (41.7%), persistent cutis marmorata (16.7%), and discoid lesions (8.3%). First and second degree heart block can resolve spontaneously in the first few months of life. 3 Cutaneous lesions are managed with emollients and mild to potent topical corticosteroids if symptoms are severe. Parents should be advised on sun avoidance or the application of sunscreen. 4 The highest incidence of abnormal laboratory results occur when the infant is 3 months old, and most cases resolve by 9 months. 9 These infants should be reviewed over a longer period to observe for future development of rheumatological diseases. 5 8 9 Approximately half of mothers of babies with neonatal lupus erythematosus are asymptomatic at the time of delivery. 3 10 Of these, nearly half of asymptomatic mothers subsequently develop connective tissue disease. [...]they should be screened for auto-antibodies and reviewed for signs and symptoms. |
doi_str_mv | 10.1136/bmj.k8 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1992016397</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1991052219</sourcerecordid><originalsourceid>FETCH-LOGICAL-b248t-e97f54d0429339fb0a385e177b397a617cc86dfe96fb7109452f207fa63ead863</originalsourceid><addsrcrecordid>eNp10E1LwzAcx_EgihtzvgSpDMRLZ_5J83QcwycYeNFzSNuEPbWdSXvw5tvY2_OVmLLpQfAUAp98CT-ELgFPASi_y6v1dCNP0BAE4ylISk_RECumUglUDtA4hDXGmFAhFWfnaEAUFQBCDdFklngTlkm7NO3X5z4kVeNtf6uTsFnVSWnt7gKdObMNdnw8R-jt4f51_pQuXh6f57NFmpNMtqlVwrGsxFmsU-VybKhkFoTIqRKGgygKyUtnFXe5AKwyRhzBwhlOrSklpyN0e-jufPPe2dDqahUKu92a2jZd0KAUwcBjLdLJH7puOl_H3_UKMCMEVFQ3B1X4JgRvnd75VWX8hwas--V0XE5vZIRXx1yXV7b8ZT87RXB9AP2DfyLfJu1xRg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1991052219</pqid></control><display><type>article</type><title>A rash that’s more than skin deep</title><source>JSTOR Archival Journals and Primary Sources Collection</source><source>BMJ Publishing</source><creator>Chin, Xinyi ; Chan, Daisy Kwai Lin ; Chong, Jin Ho</creator><creatorcontrib>Chin, Xinyi ; Chan, Daisy Kwai Lin ; Chong, Jin Ho</creatorcontrib><description>Discussion Neonatal lupus erythematosus is an acquired disease of the newborn caused by transplacental transfer of maternal anti-Ro/SSA, anti-La/SSB, and anti-U1 RNP antibodies, and has a frequency of 1 in 12500 to 20000 live births. 2 4 The condition might involve (in order of decreasing frequency) the dermatological, cardiac, hepatobiliary, and haematological systems. 2 4 5 6 Cutaneous manifestation is the commonest feature of neonatal lupus erythematosus and can present at birth 5 or within the first 4-6 weeks of life. 7 8 In one study, skin lesions were characterised as erythematous patches (91.7%), lesions resembling subacute cutaneous lupus erythematosus (50%), petechiae (41.7%), persistent cutis marmorata (16.7%), and discoid lesions (8.3%). First and second degree heart block can resolve spontaneously in the first few months of life. 3 Cutaneous lesions are managed with emollients and mild to potent topical corticosteroids if symptoms are severe. Parents should be advised on sun avoidance or the application of sunscreen. 4 The highest incidence of abnormal laboratory results occur when the infant is 3 months old, and most cases resolve by 9 months. 9 These infants should be reviewed over a longer period to observe for future development of rheumatological diseases. 5 8 9 Approximately half of mothers of babies with neonatal lupus erythematosus are asymptomatic at the time of delivery. 3 10 Of these, nearly half of asymptomatic mothers subsequently develop connective tissue disease. [...]they should be screened for auto-antibodies and reviewed for signs and symptoms.</description><identifier>ISSN: 0959-8138</identifier><identifier>EISSN: 1756-1833</identifier><identifier>DOI: 10.1136/bmj.k8</identifier><identifier>PMID: 29371179</identifier><language>eng</language><publisher>England: BMJ Publishing Group LTD</publisher><subject>Babies ; Blood tests ; Breasts ; Congenital diseases ; Corticosteroids ; Dermatitis ; Disease ; Exanthema ; Heart ; Hematology ; Immunoglobulins ; Lupus ; Mortality ; Mothers ; Newborn babies ; Patient admissions ; Risk factors</subject><ispartof>BMJ (Online), 2018-01, Vol.360, p.k8-k8</ispartof><rights>Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to</rights><rights>Copyright: 2018 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b248t-e97f54d0429339fb0a385e177b397a617cc86dfe96fb7109452f207fa63ead863</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttp://bmj.com/content/360/bmj.k8.full.pdf$$EPDF$$P50$$Gbmj$$H</linktopdf><linktohtml>$$Uhttp://bmj.com/content/360/bmj.k8.full$$EHTML$$P50$$Gbmj$$H</linktohtml><link.rule.ids>112,113,314,780,784,3194,27924,27925,77594,77595</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29371179$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chin, Xinyi</creatorcontrib><creatorcontrib>Chan, Daisy Kwai Lin</creatorcontrib><creatorcontrib>Chong, Jin Ho</creatorcontrib><title>A rash that’s more than skin deep</title><title>BMJ (Online)</title><addtitle>BMJ</addtitle><description>Discussion Neonatal lupus erythematosus is an acquired disease of the newborn caused by transplacental transfer of maternal anti-Ro/SSA, anti-La/SSB, and anti-U1 RNP antibodies, and has a frequency of 1 in 12500 to 20000 live births. 2 4 The condition might involve (in order of decreasing frequency) the dermatological, cardiac, hepatobiliary, and haematological systems. 2 4 5 6 Cutaneous manifestation is the commonest feature of neonatal lupus erythematosus and can present at birth 5 or within the first 4-6 weeks of life. 7 8 In one study, skin lesions were characterised as erythematous patches (91.7%), lesions resembling subacute cutaneous lupus erythematosus (50%), petechiae (41.7%), persistent cutis marmorata (16.7%), and discoid lesions (8.3%). First and second degree heart block can resolve spontaneously in the first few months of life. 3 Cutaneous lesions are managed with emollients and mild to potent topical corticosteroids if symptoms are severe. Parents should be advised on sun avoidance or the application of sunscreen. 4 The highest incidence of abnormal laboratory results occur when the infant is 3 months old, and most cases resolve by 9 months. 9 These infants should be reviewed over a longer period to observe for future development of rheumatological diseases. 5 8 9 Approximately half of mothers of babies with neonatal lupus erythematosus are asymptomatic at the time of delivery. 3 10 Of these, nearly half of asymptomatic mothers subsequently develop connective tissue disease. [...]they should be screened for auto-antibodies and reviewed for signs and symptoms.</description><subject>Babies</subject><subject>Blood tests</subject><subject>Breasts</subject><subject>Congenital diseases</subject><subject>Corticosteroids</subject><subject>Dermatitis</subject><subject>Disease</subject><subject>Exanthema</subject><subject>Heart</subject><subject>Hematology</subject><subject>Immunoglobulins</subject><subject>Lupus</subject><subject>Mortality</subject><subject>Mothers</subject><subject>Newborn babies</subject><subject>Patient admissions</subject><subject>Risk factors</subject><issn>0959-8138</issn><issn>1756-1833</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNp10E1LwzAcx_EgihtzvgSpDMRLZ_5J83QcwycYeNFzSNuEPbWdSXvw5tvY2_OVmLLpQfAUAp98CT-ELgFPASi_y6v1dCNP0BAE4ylISk_RECumUglUDtA4hDXGmFAhFWfnaEAUFQBCDdFklngTlkm7NO3X5z4kVeNtf6uTsFnVSWnt7gKdObMNdnw8R-jt4f51_pQuXh6f57NFmpNMtqlVwrGsxFmsU-VybKhkFoTIqRKGgygKyUtnFXe5AKwyRhzBwhlOrSklpyN0e-jufPPe2dDqahUKu92a2jZd0KAUwcBjLdLJH7puOl_H3_UKMCMEVFQ3B1X4JgRvnd75VWX8hwas--V0XE5vZIRXx1yXV7b8ZT87RXB9AP2DfyLfJu1xRg</recordid><startdate>20180125</startdate><enddate>20180125</enddate><creator>Chin, Xinyi</creator><creator>Chan, Daisy Kwai Lin</creator><creator>Chong, Jin Ho</creator><general>BMJ Publishing Group LTD</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88I</scope><scope>8AF</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ASE</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FPQ</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>K6X</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M2O</scope><scope>M2P</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20180125</creationdate><title>A rash that’s more than skin deep</title><author>Chin, Xinyi ; Chan, Daisy Kwai Lin ; Chong, Jin Ho</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b248t-e97f54d0429339fb0a385e177b397a617cc86dfe96fb7109452f207fa63ead863</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Babies</topic><topic>Blood tests</topic><topic>Breasts</topic><topic>Congenital diseases</topic><topic>Corticosteroids</topic><topic>Dermatitis</topic><topic>Disease</topic><topic>Exanthema</topic><topic>Heart</topic><topic>Hematology</topic><topic>Immunoglobulins</topic><topic>Lupus</topic><topic>Mortality</topic><topic>Mothers</topic><topic>Newborn babies</topic><topic>Patient admissions</topic><topic>Risk factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chin, Xinyi</creatorcontrib><creatorcontrib>Chan, Daisy Kwai Lin</creatorcontrib><creatorcontrib>Chong, Jin Ho</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>British Nursing Index</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>British Nursing Index (BNI) (1985 to Present)</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection</collection><collection>British Nursing Index</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Research Library</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>BMJ (Online)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chin, Xinyi</au><au>Chan, Daisy Kwai Lin</au><au>Chong, Jin Ho</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A rash that’s more than skin deep</atitle><jtitle>BMJ (Online)</jtitle><addtitle>BMJ</addtitle><date>2018-01-25</date><risdate>2018</risdate><volume>360</volume><spage>k8</spage><epage>k8</epage><pages>k8-k8</pages><issn>0959-8138</issn><eissn>1756-1833</eissn><abstract>Discussion Neonatal lupus erythematosus is an acquired disease of the newborn caused by transplacental transfer of maternal anti-Ro/SSA, anti-La/SSB, and anti-U1 RNP antibodies, and has a frequency of 1 in 12500 to 20000 live births. 2 4 The condition might involve (in order of decreasing frequency) the dermatological, cardiac, hepatobiliary, and haematological systems. 2 4 5 6 Cutaneous manifestation is the commonest feature of neonatal lupus erythematosus and can present at birth 5 or within the first 4-6 weeks of life. 7 8 In one study, skin lesions were characterised as erythematous patches (91.7%), lesions resembling subacute cutaneous lupus erythematosus (50%), petechiae (41.7%), persistent cutis marmorata (16.7%), and discoid lesions (8.3%). First and second degree heart block can resolve spontaneously in the first few months of life. 3 Cutaneous lesions are managed with emollients and mild to potent topical corticosteroids if symptoms are severe. Parents should be advised on sun avoidance or the application of sunscreen. 4 The highest incidence of abnormal laboratory results occur when the infant is 3 months old, and most cases resolve by 9 months. 9 These infants should be reviewed over a longer period to observe for future development of rheumatological diseases. 5 8 9 Approximately half of mothers of babies with neonatal lupus erythematosus are asymptomatic at the time of delivery. 3 10 Of these, nearly half of asymptomatic mothers subsequently develop connective tissue disease. [...]they should be screened for auto-antibodies and reviewed for signs and symptoms.</abstract><cop>England</cop><pub>BMJ Publishing Group LTD</pub><pmid>29371179</pmid><doi>10.1136/bmj.k8</doi></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0959-8138 |
ispartof | BMJ (Online), 2018-01, Vol.360, p.k8-k8 |
issn | 0959-8138 1756-1833 |
language | eng |
recordid | cdi_proquest_miscellaneous_1992016397 |
source | JSTOR Archival Journals and Primary Sources Collection; BMJ Publishing |
subjects | Babies Blood tests Breasts Congenital diseases Corticosteroids Dermatitis Disease Exanthema Heart Hematology Immunoglobulins Lupus Mortality Mothers Newborn babies Patient admissions Risk factors |
title | A rash that’s more than skin deep |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T15%3A34%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20rash%20that%E2%80%99s%20more%20than%20skin%20deep&rft.jtitle=BMJ%20(Online)&rft.au=Chin,%20Xinyi&rft.date=2018-01-25&rft.volume=360&rft.spage=k8&rft.epage=k8&rft.pages=k8-k8&rft.issn=0959-8138&rft.eissn=1756-1833&rft_id=info:doi/10.1136/bmj.k8&rft_dat=%3Cproquest_cross%3E1991052219%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-b248t-e97f54d0429339fb0a385e177b397a617cc86dfe96fb7109452f207fa63ead863%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1991052219&rft_id=info:pmid/29371179&rfr_iscdi=true |